SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises

News

Takeda simplifies portfolio and accelerates deleveraging through two divestitures

Takeda has agreed to Sell Xiidra to Novartis for up to $5.3 billion and also divest TachoSil to Ethicon for approximately $400 million

May 10, 2019

By : Team ABLE

BIO, NIH to hold Fifth Innovation Zone Exhibit at 2019 BIO International Convention

The Small Business Innovation Research (SBIR)-funded early-stage biomedical companies featured at the zone will showcasebiotechnology breakthroughs at BIO 2019 International Convention.

May 10, 2019

By : Team ABLE

Dyadic, Serum Institute of India partner to manufacture affordable antibody products and vaccines

According to both the companies, this collaboration is focused on making biologic vaccines & drugs accessible and more affordable to patients worldwide while lowering the financial burden on the global healthcare system.

May 09, 2019

By : Team ABLE

GVK BIO appoints Axel Schleyeras Chief Executive Officer for subsidiary Aragen Bioscience

GVK BIO has announced the appointment of Dr Axel Schleyer as Chief Executive Officer, Aragen Bioscience Inc.

May 09, 2019

By : Team ABLE

Curadevsigns licensing agreement with Takeda for anti-tumor therapeutics

According to Curadev, Takeda is an ideal partner for it to collaborate on the further development of a STING agonist,a potential immune-oncology target

May 09, 2019

By : Team ABLE

 

Archives